Aegis Vopak Terminals (AEGISVOPAK) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
22 Oct, 2026Executive summary
Q1 FY26 consolidated revenue was ₹16,401.10 lakh, up 6.5% YoY and 4.5% QoQ; net profit rose 85.1% YoY to ₹4,771.77 lakh.
Operating EBITDA was ₹1,199.04mn, with a 73.11% margin; IPO proceeds repaid ~₹2,016 crore of bank borrowings.
Two new cryogenic LPG terminals increased static LPG capacity from 70,800 MT to 200,800 MT; revenue contribution is expected from Q2 FY26.
Financial highlights
Consolidated revenue from operations was ₹16,401.10 lakh vs ₹15,402.78 lakh in Q1 FY25; total income was ₹17,334.51 lakh vs ₹15,637.00 lakh.
Consolidated PBT was ₹6,280.79 lakh vs ₹3,655.48 lakh; net profit was ₹4,771.77 lakh vs ₹2,577.70 lakh.
Operating EBITDA rose 5.6% YoY and 3.1% QoQ to ₹1,199.04mn; EBITDA margin was 73.11%.
Finance costs were ₹3,008.53 lakh vs ₹4,799.98 lakh in Q1 FY25; interest cost fell 37% sequentially, with debt-repayment savings reflected only in June.
Outlook and guidance
US$5bn aggregate capex is targeted by 2030, including US$1.2bn by next year; planned funding combines internal accruals and prudent debt.
Target debt gearing is 0.6x, with debt capped at 3.5x EBITDA; the investment hurdle is a 15% post-tax IRR.
Pipavav ammonia terminal has 36,000 MT capacity and is expected to be operational by FY26; 8,000–10,000 MT is covered by a Hindustan Zinc take-or-pay arrangement.
Pipeline connections at Kandla and Pipavav are expected to lift throughput; management expects H2 to be stronger but gave no quantified throughput guidance.
Latest events from Aegis Vopak Terminals
- Q2 earnings grew as expansion plans advanced and H1 acquisition spending drove investing outflows.AEGISVOPAK
Q2 25/26 - FY25 profit rose on Gas Terminal growth; a ₹280,000 lakh IPO followed year-end.AEGISVOPAK
Q4 24/25 - 9M revenue rose 18.3% as liquid growth and capacity expansion strengthened the platform.AEGISVOPAK
Q3 25/26 - FY26 earnings climbed as terminal expansion and acquisitions accelerated capacity growth.AEGISVOPAK
Q4 25/26 - Liquid-led growth lifted revenue and EBITDA, while PAT fell amid expansion and geopolitical risks.AEGISVOPAK
Q1 26/27